Barclays’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.34M | Buy |
271,350
+119,809
| +79% | +$1.92M | ﹤0.01% | 1727 |
|
|
2025
Q1 | $2.59M | Sell |
151,541
-158,789
| -51% | -$2.71M | ﹤0.01% | 1867 |
|
|
2024
Q4 | $7.69M | Buy |
310,330
+92,518
| +42% | +$2.29M | ﹤0.01% | 1290 |
|
|
2024
Q3 | $6.21M | Buy |
217,812
+119,372
| +121% | +$3.4M | ﹤0.01% | 1367 |
|
|
2024
Q2 | $2.6M | Sell |
98,440
-110,830
| -53% | -$2.93M | ﹤0.01% | 1531 |
|
|
2024
Q1 | $6.76M | Buy |
209,270
+41,277
| +25% | +$1.33M | ﹤0.01% | 1219 |
|
|
2023
Q4 | $7.08M | Buy |
+167,993
| New | +$7.08M | ﹤0.01% | 1267 |
|
|
2023
Q3 | – | Sell |
-2,286
| Closed | -$43K | – | 4313 |
|
|
2023
Q2 | $43K | Buy |
2,286
+2,200
| +2,558% | +$41.4K | ﹤0.01% | 3743 |
|
|
2023
Q1 | $1K | Buy |
+86
| New | +$1K | ﹤0.01% | 4250 |
|
|
2022
Q4 | – | Sell |
-6,000
| Closed | -$33K | – | 4439 |
|
|
2022
Q3 | $33K | Buy |
+6,000
| New | +$33K | ﹤0.01% | 3781 |
|